Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis
β Scribed by Michele De Simone; Riccardo Barone; Marco Vaira; Bartolomeo Aghemo; Pierroberto Mioli; Carlo Franco; Stefano Scuderi; Daniela Costamagna; Marcello Dei Poli
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 93 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Peritoneal carcinosis represents an extremely negative prognostic factor and, in a large number of cases, is rapidly lethal [1,2]. In the literature, a method that appears to be particularly effective in the treatment of this pathology consists of the cytoreduction of all visceral and peritoneal (peritonectomy) macroscopic lesions associated with hyperthermic-antiblastic peritoneal perfusion (HAPP) [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18].
The first perfusion technique was executed making use of a closed method, which includes the suture of the entire laparotomy before starting perfusion. It has the advantage of being quick to perform, but there are several disadvantages:
π SIMILAR VOLUMES
## BACKGROUND. Tumor necrosis factor (TNF), hyperthermia, and cisplatin have synergistic cytotoxicity against cancer cells in vitro. This combination may be well suited to the regional treatment of peritoneal tumor spread in patients. Continuous hyperthermic peritoneal perfusion (CHPP) is a techni
## Abstract On the basis of personal experience and a review of the literature, the authors have evaluated the results obtained with hyperthermic antiblastic perfusion (HAP) for the treatment of stage II, III and IIIAB limb melanoma. The evaluation showed that today HAP may be considered a safe an
## Abstract ## BACKGROUND. Because of scarce data from larger series and nonhomogeneous selection criteria, further information is needed on peritonectomy with hyperthermic intraperitoneal chemotherapy (HIPEC) in managing patients with ovarian peritoneal carcinomatosis. ## METHODS. In an open, p